Biopharma IPOs Had Their Best Showing In More Than A Year In Q1

Even So, Quarter Ended With No IPOs In Final Month

 
• By Mandy Jackson
  
IPO sign
Only two of six drug developers that went public in Q1 are still trading in positive territory (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business